# Ticagrelor and Peripheral Arterial Disease

> **NCT02407314** · PHASE4 · TERMINATED · sponsor: **Arkansas Heart Hospital** · enrollment: 26 (actual)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **PROCEDURE:** Percutaneous Peripheral Intervention
- **DEVICE:** Optical Coherence Tomography
- **OTHER:** Ankle Brachial Index
- **OTHER:** Six minute walk distance
- **DRUG:** Aspirin
- **DRUG:** Aspirin + Ticagrelor

## Key facts

- **NCT ID:** NCT02407314
- **Lead sponsor:** Arkansas Heart Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-06
- **Primary completion:** 2017-01-17
- **Final completion:** 2017-01-17
- **Target enrollment:** 26 (ACTUAL)
- **Why stopped:** AZ discontinued study
- **Last updated:** 2019-01-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02407314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02407314, "Ticagrelor and Peripheral Arterial Disease". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02407314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*